Shots: The LANDSCAPE and NEST clinical development program evaluates the efficacy and safety of zuranolone in patients with MDD and PPD. The presentations also include data from the P-III WATERFALL […]readmore
Tags : MDD
Shots: The P-III RAP-MD (01,02,03,04) studies involve assessing of Rapastinel (450mg, 225mg) vs PBO as an adjunctive treatment of MDD The P-III RAP-MD-04 study demonstrated unmet 1EPs & 2EPs. RAP-MD […]readmore